Add BrightSurf on Google Email

JCI Journals


JCI online early table of contents: April 13, 2009

A team of researchers has identified a class of drugs that may enhance the therapeutic effects of imatinib mesylate in treating chronic myeloid leukemia. They also developed a zebrafish model for screening potential therapies for Alzheimer's disease and identified a molecular mechanism underlying aggressive prostate cancer.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 13, 2009

JCI online early table of contents: April 6, 2009

Researchers at Duke University Medical Center have identified a signaling pathway that initiates the flushing response associated with nicotinic acid. Analysis of human cell lines revealed that beta-arrestin proteins play a key role in this process, which may be targeted to prevent side effects while maintaining therapeutic benefits. I...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 6, 2009

JCI online early table of contents: April 1, 2009

Researchers found that cannabinoids like THC have anticancer effects on human brain cancer cells by inducing autophagy. Additionally, lithium was shown to protect hippocampal nerve cells in mice treated with cranial radiation therapy, suggesting it may be a new approach to reducing long-term neurological side effects.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateApr 1, 2009

JCI table of contents: March 23, 2009

Researchers at Vanderbilt University School of Medicine have discovered that inhibiting an enzyme called 11-beta-HSD2 blocks COX-2 activity in human and mouse colorectal tumor cells, potentially providing a new approach to preventing colorectal cancer. This finding is significant because long-term inhibition of 11-beta-HSD2 did not cau...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 23, 2009

JCI online early table of contents: March 9, 2009

Two studies found that SOX9 renders melanomas sensitive to retinoic acid, stopping tumor growth and offering new hope for effective treatment. Additionally, researchers identified two enzymes crucial for ureter-bladder connection during development, which may hold key to treating congenital anomalies.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 9, 2009

JCI online early table of contents: March 2, 2009

Studies reveal that PICK1 protein plays a crucial role in acrosome formation, and its deficiency leads to low sperm count and abnormal sperm movement in male mice. This discovery may shed new light on the human disorder of globozoospermia, which affects male fertility.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateMar 2, 2009

JCI table of contents: Feb. 23, 2009

Researchers developed small molecules targeting Hsp90 in mitochondria to induce tumor cell death. This combinatorial approach may be more effective than targeting single signaling pathways. Gene therapy also restored muscle strength in a mouse model of muscular dystrophy by anchoring nNOS to the sarcolemma.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 23, 2009

JCI online early table of contents: Feb. 16, 2009

Researchers have identified a gene AEG1 that plays a key role in human liver cancer progression. Targeting this gene may provide new therapeutic options for treating liver cancer. Additionally, adenosine signaling has been linked to alcohol-induced fatty liver disease in mice, suggesting potential treatments involving adenosine receptors.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 16, 2009

JCI online early table of contents: Feb. 9, 2009

Research suggests mice without AT1A protein have a significantly prolonged lifespan. This is attributed to reduced cellular oxidation, contributing to aging. Additionally, studies investigate the role of MT1-MMP in regulating hematopoietic progenitor cells' release from bone marrow.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 9, 2009

JCI online early table of contents: Feb. 2, 2009

Researchers found a genetic variation in the HGF gene that increases breast cancer risk, suggesting shortening of a DNA region called DATE could be a useful marker. A study also revealed that high-fat diets can lead to insulin resistance by damaging mitochondria and increasing oxidative stress, but antioxidants may mitigate this effect.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateFeb 2, 2009

JCI table of contents: Jan. 26, 2009

A study by Wajahat Mehal and colleagues found that aspirin reduces liver damage caused by acetaminophen overdose. In contrast, glucocorticoid therapy may cause varying levels of brain injury in neonates, depending on the type of steroid used. These findings have important implications for treatment strategies.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 26, 2009

JCI online early table of contents: Jan. 19, 2009

A recent study by Oregon Health and Science University and the University of Colorado School of Medicine found that fetal heath is affected by mother's diet, with high-fat diets increasing the risk of developing NAFLD and obesity-related diseases in offspring. Researchers suggest a healthy maternal diet is crucial for preventing these ...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 19, 2009

Fetal health affected by mother's diet

A study found that a mother's high-fat diet during pregnancy can increase the risk of obesity-related diseases in her offspring. Reverting to a low-fat diet after a high-fat diet period reduced these risks.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 19, 2009

Opioids provide relief from neuropathic pain

A mouse model of neuropathic pain showed that immune cells producing opioids reduced symptoms, suggesting a novel approach for pain relief. Selectively targeting opioid-containing immune cells may provide natural pain relief and offer a new treatment option.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 12, 2009

JCI online early table of contents: Jan. 5, 2009

Researchers at Massachusetts General Hospital and University of Pennsylvania found that COX2 in mouse nerve cells plays a crucial role in pain caused by physical insult, while PDE5 inhibition may prevent hypertrophy in the mouse heart. These findings have implications for treating conditions such as postoperative and arthritic inflamma...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJan 5, 2009

JCI table of contents: Dec. 22, 2008

Researchers developed a method to analyze genetic variations in HCV-infected patients, predicting their response to antiviral therapy. This approach may lead to a test that identifies targets for new antiviral drugs.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 22, 2008

JCI online early table of contents: Dec. 15, 2008

Researchers have identified a new genetic cause of severe combined immunodeficiency (SCID), also known as 'Boy in the bubble syndrome'. A mutation in the DNA-PKcs gene has been found to be associated with T-B SCID, where patients lack both T and B cells. Further analysis revealed that the mutant protein retained kinase activity but was...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 15, 2008

New genetic cause of boy in the bubble syndrome

Researchers at Erasmus Medical Center have identified a new genetic cause of Severe Combined Immunodeficiency (SCID), also known as 'Boy in the bubble syndrome'. A mutation in the DNA-PKcs gene is found to be responsible for the disease, leading to impaired T cell and B cell development.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 15, 2008

JCI online early table of contents: Dec. 8, 2008

Researchers have developed a mouse model of neonatal diabetes that replicates human disease, providing new insight into the condition. Additionally, studies have identified a link between endothelial dysfunction and altered metabolic responses, particularly in relation to high-fat diets and glucose regulation.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 8, 2008

Modeling neonatal diabetes

Scientists at Oxford University created a mouse model of neonatal diabetes that mimics the human condition, showing the V59M mutant Kir6.2 protein disrupts insulin production and leads to increased blood glucose levels.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 8, 2008

JCI online early table of contents: Dec. 1, 2008

Researchers have developed a new approach to modulate gene expression using miRNA natural gene repressors for therapeutic purposes, effectively treating cancer in mice. Additionally, the study has provided insight into the molecular mechanisms controlling epithelial fluid and HCO3– secretion, which may help understand cystic fibrosis.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 1, 2008

Harnessing miRNA natural gene repressors for anticancer therapy

Scientists have developed a new approach to harness the power of microRNAs (miRNAs) as natural gene repressors for therapeutic purposes. By engineering mouse bone marrow cells to express genes only when miR-181a is downregulated, they were able to create immune cells that could target and destroy cancer cells.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateDec 1, 2008

JCI table of contents: Nov. 20, 2008

Researchers identified a potential new target for anticancer therapeutics by showing that well-oxygenated tumor cells use lactate as a fuel source, which is released by hypoxic tumor cells. Inhibiting this protein MCT1 disrupts the symbiotic relationship between tumor cell types and leads to decreased tumor growth in mice models.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 20, 2008

Preventing tumor cells from refueling: A new anti-cancer approach?

Researchers have identified a potential new target for anticancer therapeutics by showing that well-oxygenated tumor cells use lactate as a fuel, while hypoxic cells use glucose. Inhibiting this protein MCT1 disrupts the symbiotic relationship between the two cell types, leading to decreased tumor growth in mouse models.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateNov 20, 2008